The impact of SARS on society and the economy was enormous, especially in Asia. This type of epidemic is not new, but the media reaction had considerable impact. For society, the investigation of an unfolding epidemic is essential to assess the potential impact and to implement measures to contain it. The insurance business is faced with the same necessities, and to determine early whether it should adapt its business processes.1 In recent years, the infectious disease threat has diverged considerably from its previous patterns of epidemiology. As a result, new pathogens, or newly recognized diseases involving known pathogens, are being reported at an unprecedented rate. The phenomenal growth of international travel and trade has vastly increased the speed and ease with which pathogens and vectors can cross continents to cause outbreaks, epidemics and, on occasion, establish permanent residence in new areas. No country acting alone can defend its borders against this threat. Efficient defense requires a global system for gathering infectious disease intelligence, detecting outbreaks quickly and collaborating to contain their spread.
KeywordsHuman Immunodeficiency Virus West Nile Virus Severe Acute Respiratory Syndrome Acquire Immune Deficiency Syndrome Genital Ulcer Disease
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
von Overbeck J. Insurance and epidemics: SARS, West Nile virus and Nipah virus. J Insur Med
2003; 35: 24–33.Google Scholar
/crs/outbreaknetwork/en/ (WHO, accessed 22 October 2003).
Swartz MN. Recognition and management of anthrax — an update. N Engl J Med
2001; 345: 1621–6.CrossRefGoogle Scholar
Shapiro RL et al.
Botulism in the USA: a clinical and epidemiologic review. Ann Intern Med
1998; 129: 221–8.CrossRefGoogle Scholar
Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections. Lancet Infect Dis
2001; 1:334–44.CrossRefGoogle Scholar
Sack D et al.
2004; 363: 223–33.CrossRefGoogle Scholar
Stoddart B, Wilcox MH. Clostridium difficile. Curr Opin Infect Dis
2002; 15: 513–18.CrossRefGoogle Scholar
Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med
2002; 347: 1175–86.CrossRefGoogle Scholar
Fields BS et al.
Legionella and Legionnaires’ disease: 25 years of investigation. Clin Microbiol Rev
2002; 15: 506–26.CrossRefGoogle Scholar
Ustianowski AP, Lockwood DN. Leprosy: current diagnostic and treatment approaches. Curr Opin Infect Dis
2003; 16:421–7.CrossRefGoogle Scholar
Bharti AR et al.
Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis
2003; 3: 757–71.CrossRefGoogle Scholar
Hengge UR et al.
Lyme borreliosis. Lancet Infect Dis
2003; 3: 489–500.CrossRefGoogle Scholar
Krishna G, Chitkara RK. Pneumonic plague. Semin Respir Infect
2003; 18: 159–67.Google Scholar
Andrews J et al.
Community-acquired pneumonia. Curr Opin Pulm Med
2003; 9: 175–80.CrossRefGoogle Scholar
Graham SM. Salmonellosis in children in developing and developed countries and populations. Curr Opin Infect Dis
2002; 15: 507–12.CrossRefGoogle Scholar
Frieden TR at al. Tuberculosis. Lancet
2003; 362: 887–99.CrossRefGoogle Scholar
Tufariello JM et al.
Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis
2003; 3: 578–90.CrossRefGoogle Scholar
Davies PD. The world-wide increase in tuberculosis: how demographic changes, HIV infection and increasing numbers in poverty are increasing tuberculosis. Ann Med
2003; 35: 235–43.CrossRefGoogle Scholar
Corbett EL et al.
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med
2003; 163: 1009–21.CrossRefGoogle Scholar
Ayan I et al.
Childhood nasopharyngeal carcinoma: from biology to treatment. Lancet Oncol
2003; 4:13–21.CrossRefGoogle Scholar
Chien X et al.
Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med
2001; 345:1877.CrossRefGoogle Scholar
Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis
2003; 23: 47–58.CrossRefGoogle Scholar
Alter MJ. Epidemiology and prevention of hepatitis B.Semin Liver Dis
2003; 23: 39–46.CrossRefGoogle Scholar
Kao JH and Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis
2002; 2: 395–403.CrossRefGoogle Scholar
Mahomey FJ. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev
1999; 12: 351–66.Google Scholar
Yang HY et al.
Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med
2002; 347: 168–74.CrossRefGoogle Scholar
von Overbeck J. Hepatitis B infection. On the Risk 2002; 4: 50–61.Google Scholar
Flamm SL. Chronic hepatitis C virus infection.-JAMA. 2003; 289: 2413–7.CrossRefGoogle Scholar
Alter MJ et al.
The natural history of community-acquired hepatitis C in the USA. N Engl J Med
1992; 327: 1899–1905.CrossRefGoogle Scholar
Alter MJ et al.
The prevalence of hepatitis C virus infection in the USA, 1988 through 1994. N Engl J Med
1999; 341: 556–62.CrossRefGoogle Scholar
Freeman X et al.
The natural history of chronic hepatitis C: a systematic review. Hepatology
34: 809–16.Google Scholar
Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med
1999; 340:1228–33.CrossRefGoogle Scholar
Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med
2001; 345: 41–52.CrossRefGoogle Scholar
Pratt DS and Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Eng J Med
2000; 342: 1266–71.CrossRefGoogle Scholar
Shakil AO et al.
Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. Ann Intern Med
1995; 123: 330–7.CrossRefGoogle Scholar
von Overbeck J. The silent hepatitis C epidemic. On the Risk 2001; 4: 58–67.Google Scholar
Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med
2002; 347: 340–6.CrossRefGoogle Scholar
Aylward RB et al.
Global health goals: lessons from the worldwide effort to eradicate poliomyelitis. Lancet. 2003; 362: 909–14.CrossRefGoogle Scholar
Golden MR et al.
Update on syphilis: resurgence of an old problem. JAMA
2003; 290: 1510–4.CrossRefGoogle Scholar
Walker DG, Walker GJ. Forgotten but not gone: the continuing scourge of congenital syphilis. Lancet Infect Dis
2002; 2: 432–6CrossRefGoogle Scholar
Daszak P et al.
Emerging infectious diseases of wildlife — Threats to biodiversity and human health. Science
2000; 287: 443–9.CrossRefGoogle Scholar
Donnelly C et al.
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet
2003; 361: 1761–6.CrossRefGoogle Scholar
Peiris J et al.
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet
A report of the National Advisory Committee on SARS and Public Health. Learning from SARS. Health Canada
. 2003. Available at: www.hc-sc.gc.ca
/english/protection/warnings/sars/learning.html. Accessed on October 22, 2003.
© Dr R. D. C. Brackenridge, Dr Richard S. Croxson, Dr Ross Mackenzie 2006